China Universal Asset Management »

Xeris Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $82k 29k 2.85
2024-06-30 $39k 17k 2.25
2024-03-31 $59k 27k 2.21
2023-12-31 $38k 16k 2.35
2023-09-30 $6.6k 3.5k 1.86
2023-06-30 $4.7k 1.8k 2.62
2023-03-31 $3.0k 1.8k 1.63
2022-12-31 $1.8k 1.4k 1.33
2022-09-30 $2.0k 1.3k 1.57

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals